← Back to Search

Life-Steps Counseling + Text Reminders for Medication Adherence

N/A
Recruiting
Led By Steven A Safren, Ph.D.
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male sex at birth or trans man (current gender identity is male) assigned female sex at birth
Self-reports as a person who has sex with men
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, 9, 12, 15, and 18 months
Awards & highlights

Study Summary

This trial is testing different ways to help people remember to take their PrEP medication every day.

Who is the study for?
This trial is for adults who were assigned male at birth or are trans men, indicated for PrEP by CDC guidelines, and have issues like depression, substance use, or trauma. They must own a smartphone with texting/internet and be new to PrEP or unsure about sticking to it. People can't join if they're unable to consent due to severe illness/cognitive impairment, have kidney issues preventing PrEP use, or active suicidal thoughts/untreated major mental illness.Check my eligibility
What is being tested?
The study is testing how daily text message reminders and LifeSteps counseling might help people take their PrEP medication more consistently. Participants will receive interventions aimed at improving adherence and engagement in their preventive care routine.See study design
What are the potential side effects?
Since the interventions involve counseling and text messages rather than medications, there are no direct side effects from the treatments being tested in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a man or a trans man.
Select...
I identify as a man who has sex with men.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, 9, 12, 15, and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 9, 12, 15, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
TFV-DP concentrations
Wilson Medication Adherence self-report
Secondary outcome measures
Retention in PrEP care

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Life-Steps for PrePExperimental Treatment2 Interventions
Participants in this group will receive standard of care treatment plus daily text message reminders. A subset of participants who demonstrate continued adherence challenges will also receive 4-6 weekly sessions of the Lifesteps for PrEP intervention.
Group II: Standard of CareActive Control1 Intervention
Participants in this group will not receive an intervention outside the standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Daily text message reminders
2012
Completed Phase 3
~110

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
902 Previous Clinical Trials
409,826 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,449 Total Patients Enrolled
Steven A Safren, Ph.D.Principal InvestigatorUniversity of Miami
1 Previous Clinical Trials
9 Total Patients Enrolled

Media Library

Lifesteps for PrEP Clinical Trial Eligibility Overview. Trial Name: NCT04316715 — N/A
Medication Adherence Research Study Groups: Standard of Care, Life-Steps for PreP
Medication Adherence Clinical Trial 2023: Lifesteps for PrEP Highlights & Side Effects. Trial Name: NCT04316715 — N/A
Lifesteps for PrEP 2023 Treatment Timeline for Medical Study. Trial Name: NCT04316715 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrolment number of this research project?

"Affirmative. The information available on clinicaltrials.gov demonstrates that, since its original posting in September 3rd 2020, this medical experiment is still recruiting participants. A total of 250 patients are required to be enrolled from two distinct sites."

Answered by AI

Are there any open opportunities to participate in this research trial?

"Affirmative. Clinicaltrials.gov states that this medical research project, which was initially posted on September 3rd 2020 is currently recruiting participants. In total, 250 individuals are necessary to be gathered from 2 distinct locations."

Answered by AI
~16 spots leftby Aug 2024